Cerebain Biotech is a biomedical company dedicated to developing innovative treatments for dementia, particularly Alzheimer's disease. The company is focused on creating and clinically developing a minimally invasive implantable device that utilizes the Omentum, a layer of tissue that covers internal organs and produces biological agents beneficial for nerve nourishment and growth. In addition to its medical device efforts, Cerebain Biotech is also working on synthetic drug solutions aimed at addressing neurological disorders. Through its research and development initiatives, the company aims to provide effective therapeutic options for those affected by dementia.
The Diabetes Reversal Group's goal is to help people with metabolic imbalances by offering a drug-free, all-natural approach to treating diabetes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.